Adaptive Biotechnologies
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADPT and other ETFs, options, and stocks.About ADPT
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines.
ADPT Key Statistics
Stock Snapshot
Adaptive Biotechnologies(ADPT) stock is priced at $16.12, giving the company a market capitalization of 2.46B. It carries a P/E multiple of -29.96.
As of 2025-12-17, Adaptive Biotechnologies(ADPT) stock has fluctuated between $15.60 and $16.48. The current price stands at $16.12, placing the stock +3.3% above today's low and -2.2% off the high.
Adaptive Biotechnologies(ADPT) shares are trading with a volume of 2.37M, against a daily average of 3.4M.
In the last year, Adaptive Biotechnologies(ADPT) shares hit a 52-week high of $20.76 and a 52-week low of $5.81.
In the last year, Adaptive Biotechnologies(ADPT) shares hit a 52-week high of $20.76 and a 52-week low of $5.81.
ADPT News
Adaptive Biotechnologies (ADPT) announced two non-exclusive agreements with Pfizer (PFE) to leverage Adaptive’s proprietary T-cell receptor discovery capabiliti...
Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made notable portfolio adjustments on Wednesday, December 10, as revealed in daily fund disclosures. These...